Loading...
Development of a Grp94 inhibitor
Heat shock protein 90 (Hsp90) represents a promising therapeutic target for the treatment of cancer and other diseases. Unfortunately, results from clinical trials have been disappointing as off-target effects and toxicities have been observed. These detriments may be a consequence of pan-Hsp90 inhi...
Na minha lista:
| Main Authors: | , , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
2012
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3414055/ https://ncbi.nlm.nih.gov/pubmed/22642269 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1021/ja303477g |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|